{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:44:44Z","timestamp":1795106684013,"version":"4.10.3"},"reference-count":115,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,4,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Blood transfusion is the most common procedure completed during a given hospitalization in the United States. Although often life-saving, transfusions are not risk-free. One sequela that occurs in a subset of red blood cell (RBC) transfusion recipients is the development of alloantibodies. It is estimated that only 30% of induced RBC alloantibodies are detected, given alloantibody induction and evanescence patterns, missed opportunities for alloantibody detection, and record fragmentation. Alloantibodies may be clinically significant in future transfusion scenarios, potentially resulting in acute or delayed hemolytic transfusion reactions or in difficulty locating compatible RBC units for future transfusion. Alloantibodies can also be clinically significant in future pregnancies, potentially resulting in hemolytic disease of the fetus and newborn. A better understanding of factors that impact RBC alloantibody formation may allow general or targeted preventative strategies to be developed. Animal and human studies suggest that blood donor, blood product, and transfusion recipient variables potentially influence which transfusion recipients will become alloimmunized, with genetic as well as innate\/adaptive immune factors also playing a role. At present, judicious transfusion of RBCs is the primary strategy invoked in alloimmunization prevention. Other mitigation strategies include matching RBC antigens of blood donors to those of transfusion recipients or providing immunomodulatory therapies prior to blood product exposure in select recipients with a history of life-threatening alloimmunization. Multidisciplinary collaborations between providers with expertise in transfusion medicine, hematology, oncology, transplantation, obstetrics, and immunology, among other areas, are needed to better understand RBC alloimmunization and refine preventative strategies.<\/jats:p>","DOI":"10.1182\/blood-2018-08-833962","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T21:15:51Z","timestamp":1551215751000},"page":"1821-1830","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":255,"title":["Transfusion-related red blood cell alloantibodies: induction and consequences"],"prefix":"10.1182","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1785-2245","authenticated-orcid":false,"given":"Christopher A.","family":"Tormey","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT;"},{"name":"Pathology & Laboratory Medicine Service, VA Connecticut Healthcare System, West Haven, CT; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7928-3132","authenticated-orcid":false,"given":"Jeanne E.","family":"Hendrickson","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT;"},{"name":"Department of Pediatrics, Yale University School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021108572078400_B1","unstructured":"US Department of Health and Human Services (FDA). Fatalities Reported to the FDA Following Blood Collection. http:\/\/www.fda.gov\/BiologicsBloodVaccines\/SafetyAvailability. Accessed 1 August 2018."},{"issue":"Suppl 2","key":"2020021108572078400_B2","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/trf.14165","article-title":"Continued decline in blood collection and transfusion in the United States-2015","volume":"57","author":"Ellingson","year":"2017","journal-title":"Transfusion"},{"issue":"8","key":"2020021108572078400_B3","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/trf.13696","article-title":"Changes in blood center red blood cell distributions in the era of patient blood management: the trends for collection (TFC) study","volume":"56","author":"Yazer","year":"2016","journal-title":"Transfusion"},{"issue":"2","key":"2020021108572078400_B4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/j.seminhematol.2004.01.001","article-title":"Red blood cell blood group antigens: structure and function","volume":"41","author":"Reid","year":"2004","journal-title":"Semin Hematol"},{"issue":"10","key":"2020021108572078400_B5","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/j.1537-2995.2008.01815.x","article-title":"Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans","volume":"48","author":"Tormey","year":"2008","journal-title":"Transfusion"},{"issue":"3","key":"2020021108572078400_B6","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4049\/jimmunol.1700401","article-title":"Type I IFN is necessary and sufficient for inflammation-induced red blood cell alloimmunization in mice","volume":"199","author":"Gibb","year":"2017","journal-title":"J Immunol"},{"issue":"7","key":"2020021108572078400_B7","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.4049\/jimmunol.1601736","article-title":"Antigen density dictates immune responsiveness following red blood cell transfusion","volume":"198","author":"Arthur","year":"2017","journal-title":"J Immunol"},{"issue":"3","key":"2020021108572078400_B8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.21307\/immunohematology-2019-019","article-title":"DEL phenotype","volume":"33","author":"Kwon","year":"2017","journal-title":"Immunohematology"},{"issue":"11","key":"2020021108572078400_B9","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1182\/blood-2018-05-851360","article-title":"RH genotype matching for transfusion support in sickle cell disease","volume":"132","author":"Chou","year":"2018","journal-title":"Blood"},{"issue":"11","key":"2020021108572078400_B10","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2018-07-865634","article-title":"Rhesus pieces: genotype matching of RBCs","volume":"132","author":"Hendrickson","year":"2018","journal-title":"Blood"},{"issue":"18","key":"2020021108572078400_B11","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1182\/bloodadvances.2017007898","article-title":"Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia","volume":"1","author":"Chou","year":"2017","journal-title":"Blood Adv"},{"issue":"11","key":"2020021108572078400_B12","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1111\/j.1537-2995.2009.02369.x","article-title":"Positive association of DRB1 04 and DRB1 15 alleles with Fya immunization in a Southern European population","volume":"49","author":"Picard","year":"2009","journal-title":"Transfusion"},{"issue":"3","key":"2020021108572078400_B13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2141.2005.05868.x","article-title":"HLA-DRB1 polymorphism is associated with Kell immunisation","volume":"132","author":"Chiaroni","year":"2006","journal-title":"Br J Haematol"},{"issue":"6","key":"2020021108572078400_B14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1537-2995.2005.04366.x","article-title":"HLA-DRB1 alleles and Jk(a) immunization","volume":"45","author":"Reviron","year":"2005","journal-title":"Transfusion"},{"issue":"1","key":"2020021108572078400_B15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.humimm.2015.10.010","article-title":"Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease","volume":"77","author":"Tatari-Calderone","year":"2016","journal-title":"Hum Immunol"},{"issue":"8","key":"2020021108572078400_B16","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/trf.12624","article-title":"HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies","volume":"54","author":"Schonewille","year":"2014","journal-title":"Transfusion"},{"issue":"10","key":"2020021108572078400_B17","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/trf.12652","article-title":"HLA-DRB1*07:01 allele is primarily associated with the Diego a alloimmunization in a Brazilian population","volume":"54","author":"Baleotti","year":"2014","journal-title":"Transfusion"},{"issue":"3","key":"2020021108572078400_B18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1537-2995.2008.01976.x","article-title":"Anti-\u201cMi(a)\u201d immunization is associated with HLA-DRB1*0901","volume":"49","author":"Chu","year":"2009","journal-title":"Transfusion"},{"issue":"7","key":"2020021108572078400_B19","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/trf.13648","article-title":"The HLA-DRB1*15 phenotype is associated with multiple red blood cell and HLA antibody responsiveness","volume":"56","author":"Verduin","year":"2016","journal-title":"Transfusion"},{"issue":"5","key":"2020021108572078400_B20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/bjh.13639","article-title":"Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia","volume":"171","author":"Curtis","year":"2015","journal-title":"Br J Haematol"},{"issue":"3","key":"2020021108572078400_B21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.hoc.2016.01.006","article-title":"Red blood cell antibodies in hematology\/oncology patients: interpretation of immunohematologic tests and clinical significance of detected antibodies","volume":"30","author":"Hendrickson","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"2020021108572078400_B22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/trf.12070","article-title":"Antibody of undetermined specificity: frequency, laboratory features, and natural history","volume":"53","author":"Liu","year":"2013","journal-title":"Transfusion"},{"issue":"6","key":"2020021108572078400_B23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/jclinpath-2018-205001","article-title":"Identification of IgG3-specific epitope that remedies problem in diagnostic IgG subclass determination due to human genetic variation","volume":"71","author":"Howie","year":"2018","journal-title":"J Clin Pathol"},{"issue":"2","key":"2020021108572078400_B24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1471-0528.1998.tb10059.x","article-title":"The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn","volume":"105","author":"Hadley","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"2020021108572078400_B25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ajcp\/92.1.89","article-title":"Monocyte monolayer assay: an efficient noninvasive technique for predicting the severity of hemolytic disease of the newborn","volume":"92","author":"Nance","year":"1989","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"2020021108572078400_B26","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/bjh.12965","article-title":"Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn","volume":"166","author":"Kapur","year":"2014","journal-title":"Br J Haematol"},{"issue":"23","key":"2020021108572078400_B27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/blood.V126.23.660.660","article-title":"IgG alloantibodies against RBC induced by pregnancy or transfusion have unique glycosylation patterns which correlate with clinical outcomes of hemolytic disease of the fetus or newborn [abstract]","volume":"126","author":"Sonneveld","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2020021108572078400_B28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/trf.12251","article-title":"Record fragmentation due to transfusion at multiple health care facilities: a risk factor for delayed hemolytic transfusion reactions","volume":"54","author":"Unni","year":"2014","journal-title":"Transfusion"},{"issue":"3","key":"2020021108572078400_B29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1537-2995.2008.02014.x","article-title":"The persistence and evanescence of blood group alloantibodies in men","volume":"49","author":"Tormey","year":"2009","journal-title":"Transfusion"},{"issue":"12","key":"2020021108572078400_B30","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/ajh.24188","article-title":"Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion","volume":"90","author":"Nickel","year":"2015","journal-title":"Am J Hematol"},{"issue":"11","key":"2020021108572078400_B31","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/trf.13704","article-title":"Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence","volume":"56","author":"Stack","year":"2016","journal-title":"Transfusion"},{"issue":"6","key":"2020021108572078400_B32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MOH.0000000000000462","article-title":"Delayed haemolytic and serologic transfusion reactions: pathophysiology, treatment and prevention","volume":"25","author":"Siddon","year":"2018","journal-title":"Curr Opin Hematol"},{"issue":"19","key":"2020021108572078400_B33","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2009-06-227793","article-title":"Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies","volume":"114","author":"Tormey","year":"2009","journal-title":"Blood"},{"issue":"7","key":"2020021108572078400_B34","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1537-2995.2010.02629.x","article-title":"Regional registry of patient alloantibodies: first-year experience","volume":"50","author":"Schwickerath","year":"2010","journal-title":"Transfusion"},{"issue":"11","key":"2020021108572078400_B35","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/trf.13818","article-title":"The importance of antibody screens after transfusions","volume":"56","author":"Sloan","year":"2016","journal-title":"Transfusion"},{"issue":"6","key":"2020021108572078400_B36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.13494","article-title":"How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease","volume":"170","author":"Gardner","year":"2015","journal-title":"Br J Haematol"},{"issue":"12","key":"2020021108572078400_B37","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/ajh.24537","article-title":"A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease","volume":"91","author":"Mekontso Dessap","year":"2016","journal-title":"Am J Hematol"},{"issue":"12","key":"2020021108572078400_B38","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ajh.24908","article-title":"Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease","volume":"92","author":"Narbey","year":"2017","journal-title":"Am J Hematol"},{"issue":"1","key":"2020021108572078400_B39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/trf.13379","article-title":"Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series","volume":"56","author":"Nickel","year":"2016","journal-title":"Transfusion"},{"issue":"9","key":"2020021108572078400_B40","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1537-2995.2009.02199.x","article-title":"Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death","volume":"49","author":"Chadebech","year":"2009","journal-title":"Transfusion"},{"issue":"3","key":"2020021108572078400_B41","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/trf.14431","article-title":"Whole-exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition","volume":"58","author":"Mwesigwa","year":"2018","journal-title":"Transfusion"},{"issue":"3","key":"2020021108572078400_B42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tracli.2017.05.016","article-title":"Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment","volume":"24","author":"Pirenne","year":"2017","journal-title":"Transfus Clin Biol"},{"issue":"10","key":"2020021108572078400_B43","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.3324\/haematol.2018.194670","article-title":"Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease","volume":"103","author":"Chonat","year":"2018","journal-title":"Haematologica"},{"issue":"4","key":"2020021108572078400_B44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tmrv.2016.05.008","article-title":"Hemolytic disease of the fetus and newborn: modern practice and future investigations","volume":"30","author":"Hendrickson","year":"2016","journal-title":"Transfus Med Rev"},{"issue":"5","key":"2020021108572078400_B45","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","article-title":"Management and prevention of red cell alloimmunization in pregnancy: a systematic review","volume":"120","author":"Moise","year":"2012","journal-title":"Obstet Gynecol"},{"key":"2020021108572078400_B46","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/asheducation-2015.1.146","article-title":"Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn","volume":"2015","author":"Delaney","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"2020021108572078400_B47","doi-asserted-by":"crossref","first-page":"188","DOI":"10.21307\/immunohematology-2019-379","article-title":"Update on HDFN: new information on long-standing controversies","volume":"22","author":"Eder","year":"2006","journal-title":"Immunohematology"},{"issue":"12","key":"2020021108572078400_B48","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1111\/trf.13231","article-title":"Extended matched intrauterine transfusions reduce maternal Duffy, Kidd, and S antibody formation","volume":"55","author":"Schonewille","year":"2015","journal-title":"Transfusion"},{"issue":"2","key":"2020021108572078400_B49","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3324\/haematol.13356","article-title":"Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins","volume":"94","author":"Stussi","year":"2009","journal-title":"Haematologica"},{"issue":"4","key":"2020021108572078400_B50","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tmrv.2016.06.002","article-title":"Complex transfusion issues in pediatric hematopoietic stem cell transplantation","volume":"30","author":"Webb","year":"2016","journal-title":"Transfus Med Rev"},{"issue":"1","key":"2020021108572078400_B51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2014.7192","article-title":"Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype","volume":"312","author":"Hsieh","year":"2014","journal-title":"JAMA"},{"issue":"8","key":"2020021108572078400_B52","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1399-3046.2006.00608.x","article-title":"Plasma cell-rich acute cellular rejection of a transplanted kidney associated with antibody to the red cell Kidd antigen","volume":"10","author":"Hamilton","year":"2006","journal-title":"Pediatr Transplant"},{"issue":"1","key":"2020021108572078400_B53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1537-2995.2007.01060.x","article-title":"Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection?","volume":"47","author":"Lerut","year":"2007","journal-title":"Transfusion"},{"issue":"3","key":"2020021108572078400_B54","doi-asserted-by":"crossref","first-page":"90","DOI":"10.21307\/immunohematology-2019-156","article-title":"Implications of the Kidd blood group system in renal transplantation","volume":"28","author":"Rourk","year":"2012","journal-title":"Immunohematology"},{"issue":"6","key":"2020021108572078400_B55","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2020021108572078400_B56","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/MOH.0000000000000277","article-title":"Red blood cell alloimmunization: new findings at the bench and new recommendations for the bedside","volume":"23","author":"Hendrickson","year":"2016","journal-title":"Curr Opin Hematol"},{"issue":"21","key":"2020021108572078400_B57","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood.V122.21.40.40","article-title":"Red blood cell alloimmunization is influenced by inflammatory status at the time of transfusion in patients with sickle cell disease [abstract]","volume":"122","author":"Fasano","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2020021108572078400_B58","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/bjh.14307","article-title":"Red cell alloimmunisation in patients with different types of infections","volume":"175","author":"Evers","year":"2016","journal-title":"Br J Haematol"},{"issue":"5","key":"2020021108572078400_B59","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/vox.12515","article-title":"A novel network analysis tool to identify relationships between disease states and risks for red blood cell alloimmunization","volume":"112","author":"Celli","year":"2017","journal-title":"Vox Sang"},{"issue":"3","key":"2020021108572078400_B60","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/bjh.13781","article-title":"Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization","volume":"174","author":"Ryder","year":"2016","journal-title":"Br J Haematol"},{"issue":"12","key":"2020021108572078400_B61","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3324\/haematol.2017.175752","article-title":"Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome","volume":"102","author":"Singhal","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"2020021108572078400_B62","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/trf.12348","article-title":"Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention","volume":"54","author":"Vichinsky","year":"2014","journal-title":"Transfusion"},{"issue":"5","key":"2020021108572078400_B63","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.15182","article-title":"Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database","volume":"181","author":"Karafin","year":"2018","journal-title":"Br J Haematol"},{"issue":"6","key":"2020021108572078400_B64","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/08880018.2011.568595","article-title":"Blood transfusion and alloimmunization in patients with thalassemia: multicenter study","volume":"28","author":"Azarkeivan","year":"2011","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"2020021108572078400_B65","first-page":"50","article-title":"Red cell alloantibodies in patients with thalassemia [see comment]","volume":"58","author":"Spanos","year":"1990","journal-title":"Vox Sang"},{"issue":"7","key":"2020021108572078400_B66","doi-asserted-by":"crossref","first-page":"717.e711","DOI":"10.1016\/j.amjmed.2011.11.028","article-title":"High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease","volume":"125","author":"Papay","year":"2012","journal-title":"Am J Med"},{"issue":"4","key":"2020021108572078400_B67","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/trf.13999","article-title":"Cancer type predicts alloimmunization following RhD-incompatible RBC transfusions","volume":"57","author":"Arora","year":"2017","journal-title":"Transfusion"},{"issue":"8","key":"2020021108572078400_B68","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/trf.12639","article-title":"Immunosuppressants and alloimmunization against red blood cell transfusions","volume":"54","author":"Zalpuri","year":"2014","journal-title":"Transfusion"},{"issue":"6","key":"2020021108572078400_B69","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1182\/blood-2008-03-146415","article-title":"Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders [see comment]","volume":"112","author":"Higgins","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2020021108572078400_B70","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.molimm.2008.12.027","article-title":"rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease","volume":"47","author":"Tatari-Calderone","year":"2009","journal-title":"Mol Immunol"},{"key":"2020021108572078400_B71","doi-asserted-by":"crossref","first-page":"937846","DOI":"10.1155\/2013\/937846","article-title":"The association of CD81 polymorphisms with alloimmunization in sickle cell disease","volume":"2013","author":"Tatari-Calderone","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"6","key":"2020021108572078400_B72","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000369079","article-title":"A genome-wide screen for large-effect alloimmunization susceptibility loci among red blood cell transfusion recipients with sickle cell disease","volume":"41","author":"Hanchard","year":"2014","journal-title":"Transfus Med Hemother"},{"issue":"6","key":"2020021108572078400_B73","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2011-09-382655","article-title":"Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs","volume":"119","author":"Smith","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2020021108572078400_B74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/trf.15004","article-title":"Prevalence and risk factors for RBC alloantibodies in blooddonors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III)","volume":"59","author":"Karafin","year":"2019","journal-title":"Transfusion"},{"issue":"7","key":"2020021108572078400_B75","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1537-2995.2003.00443.x","article-title":"WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization","volume":"43","author":"Blumberg","year":"2003","journal-title":"Transfusion"},{"issue":"10","key":"2020021108572078400_B76","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1182\/blood.V96.10.3369","article-title":"Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent [see comment]","volume":"96","author":"Singer","year":"2000","journal-title":"Blood"},{"issue":"6","key":"2020021108572078400_B77","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000368995","article-title":"Factors influencing RBC alloimmunization: lessons learned from murine models","volume":"41","author":"Ryder","year":"2014","journal-title":"Transfus Med Hemother"},{"issue":"1","key":"2020021108572078400_B78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000345688","article-title":"Transfusion-related acute lung injury: the work of DAMPs","volume":"40","author":"Land","year":"2013","journal-title":"Transfus Med Hemother"},{"issue":"12","key":"2020021108572078400_B79","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1111\/trf.12143","article-title":"The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response","volume":"53","author":"Radwanski","year":"2013","journal-title":"Transfusion"},{"issue":"8","key":"2020021108572078400_B80","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1537-2995.2006.00894.x","article-title":"Characterization of blood components prepared from whole-blood donations after a 24-hour hold with the platelet-rich plasma method","volume":"46","author":"Thibault","year":"2006","journal-title":"Transfusion"},{"issue":"2","key":"2020021108572078400_B81","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/labmed\/lmx018","article-title":"Irradiation of red blood cells and alloimmunization","volume":"48","author":"Tormey","year":"2017","journal-title":"Lab Med"},{"issue":"1","key":"2020021108572078400_B82","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI90837","article-title":"Prolonged red cell storage before transfusion increases extravascular hemolysis","volume":"127","author":"Rapido","year":"2017","journal-title":"J Clin Invest"},{"issue":"3","key":"2020021108572078400_B83","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1309\/AJCP2J8SVWOXRLRB","article-title":"Receipt of older RBCs does not predispose D-negative recipients to anti-D alloimmunization","volume":"134","author":"Yazer","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"2020021108572078400_B84","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1111\/trf.12156","article-title":"Effect of storage of red blood cells on alloimmunization","volume":"53","author":"Zalpuri","year":"2013","journal-title":"Transfusion"},{"issue":"5","key":"2020021108572078400_B85","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.bjhh.2015.07.003","article-title":"Transfusion of older red blood cell units, cytokine burst and alloimmunization: a case-control study","volume":"37","author":"Dinardo","year":"2015","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"8","key":"2020021108572078400_B86","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.24051","article-title":"Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease","volume":"90","author":"Desai","year":"2015","journal-title":"Am J Hematol"},{"issue":"10","key":"2020021108572078400_B87","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1111\/trf.13745","article-title":"Testosterone-dependent sex differences in red blood cell hemolysis in storage, stress, and disease","volume":"56","author":"Kanias","year":"2016","journal-title":"Transfusion"},{"issue":"15","key":"2020021108572078400_B88","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/bloodadvances.2017004820","article-title":"Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: results of the REDS-III RBC-Omics study","volume":"1","author":"Kanias","year":"2017","journal-title":"Blood Adv"},{"issue":"3","key":"2020021108572078400_B89","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1537-2995.2012.03765.x","article-title":"Frequency of glucose-6-phosphate dehydrogenase-deficient red blood cell units in a metropolitan transfusion service","volume":"53","author":"Francis","year":"2013","journal-title":"Transfusion"},{"key":"2020021108572078400_B90","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ebiom.2016.08.006","article-title":"Sickle cell trait increases red blood cell storage hemolysis and post-transfusion clearance in mice","volume":"11","author":"Osei-Hwedieh","year":"2016","journal-title":"EBioMedicine"},{"key":"2020021108572078400_B91","article-title":"Evidence-based management of sickle cell disease: expert panel report","author":"US Department of Health and Human Services"},{"issue":"6 Pt 2","key":"2020021108572078400_B92","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/trf.12987","article-title":"Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease","volume":"55","author":"Casas","year":"2015","journal-title":"Transfusion"},{"issue":"1","key":"2020021108572078400_B93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/vox.12455","article-title":"Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes","volume":"112","author":"Lin","year":"2017","journal-title":"Vox Sang"},{"issue":"11","key":"2020021108572078400_B94","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1046\/j.1537-2995.2002.00234.x","article-title":"Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management","volume":"42","author":"Shirey","year":"2002","journal-title":"Transfusion"},{"issue":"11","key":"2020021108572078400_B95","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/trf.14288","article-title":"B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice","volume":"57","author":"Gibb","year":"2017","journal-title":"Transfusion"},{"issue":"25","key":"2020021108572078400_B96","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"issue":"11","key":"2020021108572078400_B97","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood-2009-04-214387","article-title":"Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model","volume":"114","author":"Desmarets","year":"2009","journal-title":"Blood"},{"issue":"12","key":"2020021108572078400_B98","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1537-2995.2012.03641.x","article-title":"Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells","volume":"52","author":"Smith","year":"2012","journal-title":"Transfusion"},{"issue":"9","key":"2020021108572078400_B99","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1182\/blood.V97.9.2872","article-title":"Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice","volume":"97","author":"Auffray","year":"2001","journal-title":"Blood"},{"issue":"9","key":"2020021108572078400_B100","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1537-2995.2006.00946.x","article-title":"Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells","volume":"46","author":"Hendrickson","year":"2006","journal-title":"Transfusion"},{"key":"2020021108572078400_B101","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3389\/fimmu.2017.00907","article-title":"CD4 depletion or CD40L blockade results in antigen-specific tolerance in a red blood cell alloimmunization model","volume":"8","author":"Natarajan","year":"2017","journal-title":"Front Immunol"},{"issue":"2","key":"2020021108572078400_B102","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/bloodadvances.2017010124","article-title":"Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice","volume":"2","author":"Patel","year":"2018","journal-title":"Blood Adv"},{"issue":"8","key":"2020021108572078400_B103","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.20959","article-title":"Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models","volume":"82","author":"Yu","year":"2007","journal-title":"Am J Hematol"},{"issue":"22","key":"2020021108572078400_B104","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1182\/blood-2008-12-193748","article-title":"Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice","volume":"113","author":"Bao","year":"2009","journal-title":"Blood"},{"issue":"11","key":"2020021108572078400_B105","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.3324\/haematol.2016.149278","article-title":"Interleukin-6 receptor-alpha signaling drives anti-RBC alloantibody production and T-follicular helper cell differentiation in a murine model of red blood cell alloimmunization","volume":"101","author":"Arneja","year":"2016","journal-title":"Haematologica"},{"issue":"6","key":"2020021108572078400_B106","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20151720","article-title":"Bridging channel dendritic cells induce immunity to transfused red blood cells","volume":"213","author":"Calabro","year":"2016","journal-title":"J Exp Med"},{"key":"2020021108572078400_B107","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3389\/fimmu.2018.00676","article-title":"Complement component 3 negatively regulates antibody response by modulation of red blood cell antigen","volume":"9","author":"Mener","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"2020021108572078400_B108","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1182\/blood-2007-04-083097","article-title":"Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes","volume":"110","author":"Zimring","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2020021108572078400_B109","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1423-0410.2008.01066.x","article-title":"Cross-linking induces non-haemolytic antigen-loss from transfused red blood cells: a potential role for rheumatoid factor","volume":"95","author":"Cadwell","year":"2008","journal-title":"Vox Sang"},{"issue":"10","key":"2020021108572078400_B110","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.4049\/jimmunol.1300885","article-title":"Antigen modulation confers protection to red blood cells from antibody through Fc\u03b3 receptor ligation","volume":"191","author":"Stowell","year":"2013","journal-title":"J Immunol"},{"issue":"10","key":"2020021108572078400_B111","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.3324\/haematol.2015.128603","article-title":"Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model","volume":"100","author":"Stowell","year":"2015","journal-title":"Haematologica"},{"issue":"26","key":"2020021108572078400_B112","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1182\/blood-2016-06-724732","article-title":"Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice","volume":"128","author":"Liu","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2020021108572078400_B113","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2008-01-132092","article-title":"Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions","volume":"112","author":"Hod","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2020021108572078400_B114","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1423-0410.2010.01327.x","article-title":"Use of mouse models to study the mechanisms and consequences of RBC clearance","volume":"99","author":"Hod","year":"2010","journal-title":"Vox Sang"},{"issue":"12","key":"2020021108572078400_B115","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1111\/j.1537-2995.2012.03647.x","article-title":"Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fc\u03b3 receptors in a murine model","volume":"52","author":"Liepkalns","year":"2012","journal-title":"Transfusion"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/133\/17\/1821\/1557096\/blood833962.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/133\/17\/1821\/1557096\/blood833962.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T13:49:57Z","timestamp":1662990597000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/133\/17\/1821\/275904\/Transfusionrelated-red-blood-cell-alloantibodies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":115,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,4,25]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2018-08-833962","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]}}}